Working papers

Greenblatt, Wesley H., Young Hou, and Sukhun Kang. 2025. Do Biomedical Researchers Study Topics Related to their Own Ethnicities? Evidence from the NIH.

Azoulay, Pierre, and Wesley H. Greenblatt. 2025. Does Peer Review Penalize Scientific Risk Taking? Evidence from NIH Grant Renewals.  NBER Working Paper No. 33495.

Greenblatt, Wesley H. 2022. Anchoring Exploration: Knowledge Certification and the Dynamics of Innovation. 

Management and economics publications

Fisar, Milos, Ben Greiner, Christoph Huber, Elena Katok, Ali I Ozkes, and the Management Science Reproducibility Collaboration. 2024. Reproducibility in Management Science.  Management Science, 70(3):1343-1356.

Greenblatt, Wesley H., Charu N. Gupta, and Jennifer Kao. 2023.  Drug Repurposing During the COVID-19 Pandemic:  Lessons for Expediting Drug Development and Access.  Health Affairs, 42(3):424-432.

Azoulay, Pierre, Wesley H. Greenblatt, and Misty L. Heggeness. 2021. Long-term Effects from Early Exposure to Research: Evidence from the NIH "Yellow Berets." Research Policy, 50(9):104332.

Greenblatt, Wesley H. 2021. Proportion, Type and Characteristics of Physician Entrepreneurship in Massachusetts. JAMA Network Open, 4(1):e2026938.

Other publications

Rubenstein, Eric M., Stefan G. Kreft, Wesley Greenblatt, Robert Swanson, and Mark Hochstrasser. 2012. Aberrant substrate engagement of the ER translocon triggers degradation by the Hrd1 ubiquitin ligase. Journal of Cell Biology, 197(6):761-773.

Greenblatt, Wesley H., Chin Hur, Amy B. Knudsen, John A. Evans, Daniel C. Chung, and G. Scott Gazelle. 2009. Cost-Effectiveness of Prophylactic Surgery for Duodenal Cancer in Familial Adenomatous Polyposis.  Cancer Epidemiology, Biomarkers and Prevention, 18(10):2677-2684.